Atazanavir Sulfate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

41 API Suppliers, 25 USDMF, 7 CEP/COS, 15 EU WC, 2 KDMF, 18 NDC API, 20 Listed Suppliers, $ API Reference Price

FINISHED DOSAGE FORMULATIONS

67 FDF Dossiers, 42 FDA Orange Book, 8 Europe, 11 Canada, 6 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 300MG BASE;150MG, CAPSULE;ORAL - EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - EQ 200MG BASE, CAPSULE;ORAL - EQ 300MG BASE

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 1 SPI Pharma, 8 DKSH, 4 Faran Shimi Pharmaceutical, 5 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 4 ACG Worldwide, 1 Actylis, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 8 BASF, 6 DFE Pharma, 1 Finar, 6 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 17 Kerry, 3 Lonza Capsugel, 12 Microlex e.U, 2 Pharmatrans-Sanaq, 4 Pluviaendo, 4 Prachin Chemical, 1 Qualicaps, 14 Roquette, 3 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 11 Sigachi Industries, 1 Valens Pharmachem, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

43 Fillers, Diluents & Binders, 22 Disintegrants & Superdisintegrants, 20 Thickeners and Stabilizers, 16 Lubricants & Glidants, 15 Granulation, 14 Direct Compression, 13 Coating Systems & Additives, 8 Film Formers & Plasticizers, 8 Empty Capsules, 7 Topical, 7 Emulsifying Agents, 7 Co-Processed Excipients, 7 Taste Masking, 4 Controlled & Modified Release, 4 Parenteral, 4 Solubilizers, 3 Coloring Agents, 3 Chewable & Orodispersible Aids, 3 Surfactant & Foaming Agents, 2 Rheology Modifiers, 1 API Stability Enhancers